F

J

FAYETTE , J.

Last name: FAYETTE

First name: J.

2024 (v1)

Journal article

Metadata-only

Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

Guigay, J. Ortholan, C. Vansteene, D.

BACKGROUND: At present, there is no established standard treatment for frail older patients with recurrent or metastatic head and neck squamous cell carcinoma. We aimed to compare the efficacy and safety of cetuximab to those of methotrexate (the reference regimen) in this population. METHODS: This randomised, open-label, phase 3 trial was done...

Uploaded on: July 27, 2024